Don Schneider, Piper Sandler deputy head of U.S. policy, and Marc Goldwein, CRFB SVP and senior policy director, join CNBC's ...

Ameritas Advisory Services LLC grew its holdings in shares of Accenture plc (NYSE:ACN – Free Report) by 11.7% in the 4th ...

Jefferies analyst Roger Song confirmed a Buy rating and a price target of $8.00 for IO Biotech (NASDAQ:IOBT) shares. The ...

Trupanion (NASDAQ:TRUP) shares rallied more than 4% Thursday following an upgrade from Piper Sandler analysts, who shifted their rating to Overweight from Neutral. In a note, the analysts cited ...

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its fourth quarter and full year 2024 financial results prior to the opening of the ...

Piper Sandler analyst Derek Podhaizer maintained a Buy rating on Halliburton (HAL – Research Report) today and set a price target of $36.00. The company’s shares closed yesterday at $28.48.

In a report released today, Arvind Ramnani from Piper Sandler maintained a Buy rating on Mastercard (MA – Research Report), with a price target of $591.00. The company’s shares closed ...

Pets insurance company Trupanion (NASDAQ:TRUP) was upgraded at Piper Sandler on improving investor sentiment and several favorable catalysts. The catalysts include the 2025 guidance, faster-than ...

As of 2:42:41 PM EST. Market Open. MINNEAPOLIS, January 23, 2025--Piper Sandler Companies to Announce Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call on January 31 ...

Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Investing.com -- Shares of Travelers (NYSE: NYSE:TRV) climbed 1% as Piper Sandler shifted its stance on the insurance giant, upgrading the stock from Neutral to Overweight and significantly ...